|
CAR T-Cell Therapy:
Chimeric Antigen Receptor (CAR) T-cell therapy is a ground-breaking approach that reprograms a patient's T cells to seek out and destroy cancer cells. This process involves collecting T cells from the patient's blood and genetically modifying them in the laboratory to express CARs on their surface. These CARs are designed to recognize and bind to specific proteins (antigens) on the surface of cancer cells. Once the modified T cells are infused back into the patient, they multiply and launch a targeted attack against the cancer cells.
CAR T-cell therapy has shown remarkable success in treating certain types of blood cancers, such as acute lymphoblastic leukemia (ALL) in children and young adults, and certain types of lymphomas in adults.For patients with these types of cancers who have relapsed or not responded to conventional treatments, CAR T-cell therapy offers a powerful and potentially life-saving option. The success of CAR T-cell therapy has led to extensive
|